Trial Details
RecruitingBasic Information
| Clinical ID | c2665 |
|---|---|
| Identifier | NCT03917303 |
| Trial Title | Control Crohn Safe With Episodic Adalimumab Monotherapy as First Line Treatment Study. |
| Trial URL | Visit Original Page |
Study Information
| Study Results | No results available |
|---|---|
| Conditions | Crohn Disease;Inflammatory Bowel Diseases |
| Interventions | Drug: Adalimumab;Drug: standard step-up care |
Participant Information
| Sponsor | Maastricht University Medical Center |
|---|---|
| City | - |
| Country/Region | Netherlands |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | Interventional |
|---|---|
| Phase | PHASE4 |
Time Information
| Start Date | 2025-04-24 |
|---|---|
| Primary Completion Date | - |
| Completion Date | - |